Goldman Sachs’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $950K | Buy |
177,312
+18,724
| +12% | +$100K | ﹤0.01% | 3881 |
|
|
2025
Q1 | $847K | Sell |
158,588
-57,954
| -27% | -$309K | ﹤0.01% | 3929 |
|
|
2024
Q4 | $1.94M | Sell |
216,542
-55,300
| -20% | -$494K | ﹤0.01% | 3499 |
|
|
2024
Q3 | $2.99M | Sell |
271,842
-123,303
| -31% | -$1.36M | ﹤0.01% | 3089 |
|
|
2024
Q2 | $3.6M | Buy |
395,145
+181,611
| +85% | +$1.65M | ﹤0.01% | 2841 |
|
|
2024
Q1 | $3.01M | Buy |
213,534
+197,158
| +1,204% | +$2.77M | ﹤0.01% | 2933 |
|
|
2023
Q4 | $126K | Sell |
16,376
-12,154
| -43% | -$93.3K | ﹤0.01% | 4429 |
|
|
2023
Q3 | $213K | Buy |
28,530
+2,897
| +11% | +$21.6K | ﹤0.01% | 4236 |
|
|
2023
Q2 | $214K | Sell |
25,633
-46,524
| -64% | -$388K | ﹤0.01% | 4368 |
|
|
2023
Q1 | $960K | Buy |
+72,157
| New | +$960K | ﹤0.01% | 3681 |
|
|
2021
Q4 | – | Sell |
-11,221
| Closed | -$99K | – | 5530 |
|
|
2021
Q3 | $99K | Sell |
11,221
-2,232
| -17% | -$19.7K | ﹤0.01% | 5052 |
|
|
2021
Q2 | $170K | Buy |
13,453
+7,621
| +131% | +$96.3K | ﹤0.01% | 4972 |
|
|
2021
Q1 | $101K | Buy |
5,832
+3,166
| +119% | +$54.8K | ﹤0.01% | 5037 |
|
|
2020
Q4 | $34K | Sell |
2,666
-2,444
| -48% | -$31.2K | ﹤0.01% | 4592 |
|
|
2020
Q3 | $190K | Sell |
5,110
-1,897
| -27% | -$70.5K | ﹤0.01% | 4079 |
|
|
2020
Q2 | $270K | Buy |
+7,007
| New | +$270K | ﹤0.01% | 3871 |
|
|
2018
Q1 | – | Sell |
-273
| Closed | -$24K | – | 4190 |
|
|
2017
Q4 | $24K | Buy |
+273
| New | +$24K | ﹤0.01% | 4089 |
|
|
2017
Q2 | – | Sell |
-318
| Closed | -$31K | – | 4396 |
|
|
2017
Q1 | $31K | Buy |
318
+106
| +50% | +$10.3K | ﹤0.01% | 4279 |
|
|
2016
Q4 | $46K | Buy |
+212
| New | +$46K | ﹤0.01% | 4234 |
|
|
2016
Q2 | – | Sell |
-185
| Closed | -$56K | – | 4509 |
|
|
2016
Q1 | $56K | Buy |
+185
| New | +$56K | ﹤0.01% | 4182 |
|
|
2015
Q3 | – | Sell |
-417
| Closed | -$305K | – | 4551 |
|
|
2015
Q2 | $305K | Buy |
+417
| New | +$305K | ﹤0.01% | 3702 |
|